![Andrew Hamer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Hamer
Hoofd Techniek/Wetenschap/O&O bij CARDIOL THERAPEUTICS INC.
Vermogen: 627 176 $ op 31-05-2024
Actieve functies van Andrew Hamer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
CARDIOL THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 29-03-2021 | - |
Loopbaan van Andrew Hamer
Eerdere bekende functies van Andrew Hamer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01-01-2018 | 01-03-2021 |
CAPRICOR THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 22-11-2013 | 30-07-2015 |
Capricor, Inc.
![]() Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Hoofd Techniek/Wetenschap/O&O | 01-11-2013 | - |
Opleiding van Andrew Hamer
University of Otago | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Nieuw-Zeeland | 2 |
Canada | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
CARDIOL THERAPEUTICS INC. | Health Technology |
AMGEN INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Capricor, Inc.
![]() Capricor, Inc. BiotechnologyHealth Technology Part of Capricor Therapeutics, Inc., Capricor, Inc. is a company that provides cardiac stem cell therapeutics biotechnology services. The company is based in Los Angeles, CA. The company was founded by Linda Marbán. Linda Marbán has been the CEO since incorporation. Capricor was acquired by Capricor Therapeutics, Inc. on November 21, 2013. | Health Technology |
- Beurs
- Insiders
- Andrew Hamer
- Ervaring